Call Matthew 4
4 · iTeos Therapeutics, Inc. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
Call Matthew
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-03-01+72,000→ 72,000 totalExercise: $41.58Exp: 2031-03-01→ Common Stock (72,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest over 4 years, with 25% vesting on March 1, 2022 and thereafter in equal monthly installments over the next 36 months subject to the Reporting Person's continued service to the Issuer.